To include your compound in the COVID-19 Resource Center, submit it here.

Vosaroxin: Phase III ongoing

Sunesis said an independent DSMB recommended continuation of the double-blind, international Phase III VALOR trial based on a safety review.

Read the full 208 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE